These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3116815)

  • 21. Hereditary thrombocythemia caused by a thrombopoietin (THPO) gain-of-function mutation associated with multiple myeloma and congenital limb defects.
    Stockklausner C; Echner N; Klotter AC; Hegenbart U; Dreger P; Kulozik AE
    Ann Hematol; 2012 Jul; 91(7):1129-33. PubMed ID: 22453305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial analysis of JAK2 mutation in a patient who developed essential thrombocythemia after orthotopic liver transplantation.
    Au WY; Fung A; Liu CL; Fan ST; Ma SK; Liang R; Kwong YL
    Am J Hematol; 2006 Nov; 81(11):880-2. PubMed ID: 16929538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated spleen agenesis: a rare cause of thrombocytosis mimicking essential thrombocythemia.
    Chanet V; Tournilhac O; Dieu-Bellamy V; Boiret N; Spitz P; Baud O; Darcha C; Travade P; Laurichesse H
    Haematologica; 2000 Nov; 85(11):1211-3. PubMed ID: 11064471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombocytosis and essential thrombocythemia in childhood].
    Mialou V; Kagialis-Girard S; Galambrun C; Pondarré C; Kebaili K; Ffrench M; Pagès MP; Bertrand Y
    Arch Pediatr; 2005 Aug; 12(8):1249-54. PubMed ID: 15908186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility gene card for: hereditary thrombocythemia.
    Hussein K; Percy M; McMullin MF; Schwarz J; Schnittger S; Porret N; Martinez-Aviles LM; Paricio BB; Giraudier S; Skoda R; Lippert E; Hermouet S; Cario H
    Eur J Hum Genet; 2014 Feb; 22(2):. PubMed ID: 23736217
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
    Turakhia SK; Murugesan G; Cotta CV; Theil KS
    J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies.
    Veselovska J; Pospisilova D; Pekova S; Horvathova M; Solna R; Cmejlova J; Cmejla R; Belickova M; Mihal V; Stary J; Divoky V
    Leuk Res; 2008 Mar; 32(3):369-77. PubMed ID: 17719087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis.
    Percy MJ; Rumi E
    Am J Hematol; 2009 Jan; 84(1):46-54. PubMed ID: 19006225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Schmitt-Graeff AH; Teo SS; Olschewski M; Schaub F; Haxelmans S; Kirn A; Reinecke P; Germing U; Skoda RC
    Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of specific thrombotic accidents in patients with thrombocytosis.
    Randi ML; Fabris F; Tison T; Barbone E; Rossi C; Girolami A
    Haematologia (Budap); 1993; 25(3):149-52. PubMed ID: 8119627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia.
    Lazarevic V; Andersson C; Wahlin A; Golovleva I
    Cancer Genet Cytogenet; 2006 Feb; 165(1):87-9. PubMed ID: 16490605
    [No Abstract]   [Full Text] [Related]  

  • 32. Dermoscopic description of a patient with thrombocythemia and factor V Leiden mutation-associated Degos' disease.
    Darwich E; Guilabert A; Mascaró JM; Malvehy J; Puig S; Fernandez-Figueras M; Herrero C
    Int J Dermatol; 2011 May; 50(5):604-6. PubMed ID: 21506980
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevated telomerase activity in essential thrombocythemia with extreme thrombocytosis.
    Kim M; Oh B; Kim TY; Yoon SS; Kim SY; Hwang SM; Lee DS
    Clin Biochem; 2014 Apr; 47(6):389-92. PubMed ID: 24440836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myeloid leukemia associated with t(1;3)(p36;q21) and extreme thrombocytosis: a clinical study with literature review.
    Lim G; Kim MJ; Oh SH; Cho SY; Lee HJ; Suh JT; Lee J; Lee WI; Cho KS; Park TS
    Cancer Genet Cytogenet; 2010 Dec; 203(2):187-92. PubMed ID: 21156232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombocytosis and thrombosis.
    Vannucchi AM; Barbui T
    Hematology Am Soc Hematol Educ Program; 2007; ():363-70. PubMed ID: 18024652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. XYY male with essential thrombocythemia in childhood.
    Okada H; Imai T; Itoh S; Isobe K; Onishi S
    Int J Hematol; 2000 Jan; 71(1):55-8. PubMed ID: 10729994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Occurrence and clinical relevance of thrombocytosis].
    Gonzenbach R; Grimm J; Trachsler M; Rhyner K
    Schweiz Med Wochenschr; 1982 Jan; 112(2):38-41. PubMed ID: 7071570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytosis and thrombocythemia: qualitative platelet abnormalities.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1265-72. PubMed ID: 2629455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
    Kabutomori O; Kanakura Y; Iwatani Y
    Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.
    Ziakas PD
    Haematologica; 2008 Sep; 93(9):1412-4. PubMed ID: 18641024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.